Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.

Sonmez O, Esatoglu SN, Ucar D, Kaymaz E, Ozguler Y, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Uygunoglu U, Cigdem Oba M, Kutlubay Z, Hatemi AI, Celik AF, Hamuryudan V, Hatemi G

Open source

DOI: 10.1093/rheumatology/keag510
Published: 2026 Sep 16
Container: Rheumatology (Oxford, England)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag510,
  title = {Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.},
  author = {Sonmez O and Esatoglu SN and Ucar D and Kaymaz E and Ozguler Y and Ugurlu S and Seyahi E and Melikoglu M and Fresko I and Uygunoglu U and Cigdem Oba M and Kutlubay Z and Hatemi AI and Celik AF and Hamuryudan V and Hatemi G},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag510},
  url = {https://doi.org/10.1093/rheumatology/keag510}
}

RIS

TY  - JOUR
TI  - Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.
AU  - Sonmez O
AU  - Esatoglu SN
AU  - Ucar D
AU  - Kaymaz E
AU  - Ozguler Y
AU  - Ugurlu S
AU  - Seyahi E
AU  - Melikoglu M
AU  - Fresko I
AU  - Uygunoglu U
AU  - Cigdem Oba M
AU  - Kutlubay Z
AU  - Hatemi AI
AU  - Celik AF
AU  - Hamuryudan V
AU  - Hatemi G
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag510
UR  - https://doi.org/10.1093/rheumatology/keag510
ER  -

APA

O, S., SN, E., D, U., E, K., Y, O., S, U., E, S., M, M., I, F., U, U., M, C. O., Z, K., AI, H., AF, C., V, H., & G, H. (2026). Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag510

Source records

pubmed · retrieved 2026-09-26T11:51:54.888Z
europe-pmc · retrieved 2026-09-26T11:51:54.878Z